InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
T+90 hit rate
0%
T+90 mean return
-37.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Hull Hans, Directeur Commercial. Director active across 1 company, notably Pliant Therapeutics, INC.. Aggregated, 15 filings have been recorded. Split: 0 buy · 6 sells. Total volume traded: €1.2m. Activity tracked since 26 May 2021. The latest transaction was disclosed on 23 January 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations15 total
40,150 shares0Common StockSEC:0001746473-25-000015:0
15,936 shares@ US$11.201114.5% of flowCommon StockSEC:0001746473-25-000004:0
9,900 shares@ US$11.568.8% of flowCommon StockSEC:0001746473-24-000127:0
19,337 shares0Common StockSEC:0001746473-24-000117:0
31,500 shares0Common StockSEC:0001746473-24-000016:0
9,786 shares@ US$17.2313.0% of flowCommon StockSEC:0001746473-24-000004:0
13,069 shares@ US$20.0020.0% of flowCommon StockSEC:0001209191-23-044892:0
17,937 shares@ US$18.009124.1% of flowCommon StockSEC:0001209191-23-042829:0
35,156 shares0Common StockSEC:0001209191-23-042658:0
9,036 shares@ US$26.520918.4% of flowCommon StockSEC:0001209191-23-022369:0
17,578 shares0Common StockSEC:0001209191-23-021919:0
54,000 shares0Common StockSEC:0001140361-23-003180:0
17,578 shares0Common StockSEC:0001140361-22-046567:0
4,500 shares@ US$2.0850.0% of flowCommon StockSEC:0001209191-21-036690
4,500 shares@ US$2.080.010% mcap50.0% of flowCommon StockSEC:0001209191-21-036690:0
15 of 15 declarations
About Hull Hans
Hans Hull is the Chief Business Officer at PLIANT THERAPEUTICS, INC. He is responsible for the company's business strategy, contributing to expansion and innovation. His expertise is crucial for developing new market opportunities.
